Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme
Abstract Background Real-world data on sufficient/insufficient response, and predictors of insufficient response, to acute treatments for migraine are limited in Japan. This study aimed to identify factors associated with insufficient response to acute treatment of migraine by exploring significant...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | BMC Neurology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12883-020-01848-4 |
_version_ | 1819113171042959360 |
---|---|
author | Koichi Hirata Kaname Ueda Wenyu Ye Yongin Kim Mika Komori James Jackson Sarah Cotton Narayan Rajan Tamas Treuer |
author_facet | Koichi Hirata Kaname Ueda Wenyu Ye Yongin Kim Mika Komori James Jackson Sarah Cotton Narayan Rajan Tamas Treuer |
author_sort | Koichi Hirata |
collection | DOAJ |
description | Abstract Background Real-world data on sufficient/insufficient response, and predictors of insufficient response, to acute treatments for migraine are limited in Japan. This study aimed to identify factors associated with insufficient response to acute treatment of migraine by exploring significant differences between people with migraine who sufficiently/insufficiently respond to prescribed acute treatment in Japan. Methods This was a retrospective analysis of 2014 Adelphi Migraine Disease Specific Programme cross-sectional survey data collected from physicians and their consulting adult patients with migraine in Japan. Insufficient responders to prescribed acute treatment were patients who achieved headache pain freedom within 2 h of acute treatment in no more than three of their last five migraine attacks. Factors associated with insufficient response to prescribed acute migraine treatment were identified using backward logistic regression. Results Overall, 227/538 (42.2%) patients were classified as insufficient responders to prescribed acute migraine treatment. Significantly more insufficient responders than sufficient responders had consulted a neurologist or a migraine/headache specialist, and had chronic migraine or medication-overuse or tension-type headaches (p < 0.05). More insufficient responders than sufficient responders reported taking acute treatment when/after the pain started (77.0 vs. 68.9%) than at first sign of migraine (p < 0.05). Compared with sufficient responders, insufficient responders reported a significantly higher mean ± standard deviation (SD) Migraine Disability Assessment total score (12.7 ± 23.3 vs. 5.8 ± 10.4, p < 0.001) and lower quality of life (EuroQol-5 Dimensions utility score 0.847 ± 0.19 vs. 0.883 ± 0.16, p = 0.024). Factors significantly associated with insufficient response to acute treatment included seeing a neurologist versus an internist (odds ratio [OR] 1.93; 95% confidence interval [CI] 1.29–2.88; p = 0.002), taking acute medication when/after pain started versus at first sign of migraine (OR 1.65; 95% CI 1.05–2.60; p = 0.030), a higher MIDAS total score (OR 1.04; 95% CI 1.02–1.06; p < 0.001), and presence of comorbid cardiovascular disease (OR 0.53; 95% CI 0.28–0.98; p = 0.044). Conclusions Many people with migraine in Japan struggle to adequately treat migraine attacks with prescribed acute medication and exhibit high levels of unmet need for acute treatment. Optimized management strategies utilizing existing therapeutic options as well as additional effective therapeutic options for migraine are required to improve symptoms and quality of life. |
first_indexed | 2024-12-22T04:25:09Z |
format | Article |
id | doaj.art-d21a178688634026b194250f283b3e13 |
institution | Directory Open Access Journal |
issn | 1471-2377 |
language | English |
last_indexed | 2024-12-22T04:25:09Z |
publishDate | 2020-07-01 |
publisher | BMC |
record_format | Article |
series | BMC Neurology |
spelling | doaj.art-d21a178688634026b194250f283b3e132022-12-21T18:39:11ZengBMCBMC Neurology1471-23772020-07-0120111110.1186/s12883-020-01848-4Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific ProgrammeKoichi Hirata0Kaname Ueda1Wenyu Ye2Yongin Kim3Mika Komori4James Jackson5Sarah Cotton6Narayan Rajan7Tamas Treuer8Department of Neurology, Dokkyo Medical UniversityEli Lilly Japan K.KEli Lilly and CompanyEli Lilly and CompanyEli Lilly Japan K.KAdelphi Real WorldAdelphi Real WorldEli Lilly AustraliaLilly Hungária KftAbstract Background Real-world data on sufficient/insufficient response, and predictors of insufficient response, to acute treatments for migraine are limited in Japan. This study aimed to identify factors associated with insufficient response to acute treatment of migraine by exploring significant differences between people with migraine who sufficiently/insufficiently respond to prescribed acute treatment in Japan. Methods This was a retrospective analysis of 2014 Adelphi Migraine Disease Specific Programme cross-sectional survey data collected from physicians and their consulting adult patients with migraine in Japan. Insufficient responders to prescribed acute treatment were patients who achieved headache pain freedom within 2 h of acute treatment in no more than three of their last five migraine attacks. Factors associated with insufficient response to prescribed acute migraine treatment were identified using backward logistic regression. Results Overall, 227/538 (42.2%) patients were classified as insufficient responders to prescribed acute migraine treatment. Significantly more insufficient responders than sufficient responders had consulted a neurologist or a migraine/headache specialist, and had chronic migraine or medication-overuse or tension-type headaches (p < 0.05). More insufficient responders than sufficient responders reported taking acute treatment when/after the pain started (77.0 vs. 68.9%) than at first sign of migraine (p < 0.05). Compared with sufficient responders, insufficient responders reported a significantly higher mean ± standard deviation (SD) Migraine Disability Assessment total score (12.7 ± 23.3 vs. 5.8 ± 10.4, p < 0.001) and lower quality of life (EuroQol-5 Dimensions utility score 0.847 ± 0.19 vs. 0.883 ± 0.16, p = 0.024). Factors significantly associated with insufficient response to acute treatment included seeing a neurologist versus an internist (odds ratio [OR] 1.93; 95% confidence interval [CI] 1.29–2.88; p = 0.002), taking acute medication when/after pain started versus at first sign of migraine (OR 1.65; 95% CI 1.05–2.60; p = 0.030), a higher MIDAS total score (OR 1.04; 95% CI 1.02–1.06; p < 0.001), and presence of comorbid cardiovascular disease (OR 0.53; 95% CI 0.28–0.98; p = 0.044). Conclusions Many people with migraine in Japan struggle to adequately treat migraine attacks with prescribed acute medication and exhibit high levels of unmet need for acute treatment. Optimized management strategies utilizing existing therapeutic options as well as additional effective therapeutic options for migraine are required to improve symptoms and quality of life.http://link.springer.com/article/10.1186/s12883-020-01848-4Adelphi Migraine Disease Specific ProgrammeJapanMigraineQuality of lifeRetrospective studyTreatment satisfaction |
spellingShingle | Koichi Hirata Kaname Ueda Wenyu Ye Yongin Kim Mika Komori James Jackson Sarah Cotton Narayan Rajan Tamas Treuer Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme BMC Neurology Adelphi Migraine Disease Specific Programme Japan Migraine Quality of life Retrospective study Treatment satisfaction |
title | Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme |
title_full | Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme |
title_fullStr | Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme |
title_full_unstemmed | Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme |
title_short | Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme |
title_sort | factors associated with insufficient response to acute treatment of migraine in japan analysis of real world data from the adelphi migraine disease specific programme |
topic | Adelphi Migraine Disease Specific Programme Japan Migraine Quality of life Retrospective study Treatment satisfaction |
url | http://link.springer.com/article/10.1186/s12883-020-01848-4 |
work_keys_str_mv | AT koichihirata factorsassociatedwithinsufficientresponsetoacutetreatmentofmigraineinjapananalysisofrealworlddatafromtheadelphimigrainediseasespecificprogramme AT kanameueda factorsassociatedwithinsufficientresponsetoacutetreatmentofmigraineinjapananalysisofrealworlddatafromtheadelphimigrainediseasespecificprogramme AT wenyuye factorsassociatedwithinsufficientresponsetoacutetreatmentofmigraineinjapananalysisofrealworlddatafromtheadelphimigrainediseasespecificprogramme AT yonginkim factorsassociatedwithinsufficientresponsetoacutetreatmentofmigraineinjapananalysisofrealworlddatafromtheadelphimigrainediseasespecificprogramme AT mikakomori factorsassociatedwithinsufficientresponsetoacutetreatmentofmigraineinjapananalysisofrealworlddatafromtheadelphimigrainediseasespecificprogramme AT jamesjackson factorsassociatedwithinsufficientresponsetoacutetreatmentofmigraineinjapananalysisofrealworlddatafromtheadelphimigrainediseasespecificprogramme AT sarahcotton factorsassociatedwithinsufficientresponsetoacutetreatmentofmigraineinjapananalysisofrealworlddatafromtheadelphimigrainediseasespecificprogramme AT narayanrajan factorsassociatedwithinsufficientresponsetoacutetreatmentofmigraineinjapananalysisofrealworlddatafromtheadelphimigrainediseasespecificprogramme AT tamastreuer factorsassociatedwithinsufficientresponsetoacutetreatmentofmigraineinjapananalysisofrealworlddatafromtheadelphimigrainediseasespecificprogramme |